SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

Share Price is delayed by 15 minutes
Get Live Data
17.50    0.00 (0.00%)
Bid:
17.00
Ask:
18.00
Spread: 1.00 (5.882%)
Market Cap: £15.85m
TMG Live PriceLast checked at - London Stock Exchange

Intraday The Mission Group Share Chart

Trading Update

25 Jul 2024 07:00

RNS Number : 7260X
Mission Group PLC (The)
25 July 2024
 

25th July 2024

The Mission Group plc

("MISSION" the "Company" or the "Group")

 

Trading Update

 

The MISSION Group plc (AIM: TMG), creator of Work That CountsTM, comprising a group of digital marketing and communications Agencies, provides a trading update for the six months ended 30 June 2024 ("the Period" or "H1").  

 

TRADING

 

Trading in the Period has continued in line with the Board's expectations. MISSION is pleased to report further, notable new Client wins in the weeks since its 17 June Trading Update across all business segments. Looking ahead into H2, the new business pipeline remains strong.

 

FINANCIAL PERFORMANCE

 

The Group expects to report organic revenue growth of 2.5 percent to £42.5m (30 June 2023: £41.4m) for the Period, with headline1 operating profit of £2.6m (30 June 2023: £2.0m reported, £2.5m from continuing activities2), in line with management expectations. Headline profit before tax for the period has been impacted by higher interest rates and is expected to be £1.1m (30 June 2023: £1.0m reported, £1.5m from continuing activities).

 

Revenue growth has been driven by strong progress across MISSION's Property and Sports & Entertainment sectors whilst the timing of the UK general election delayed some government expenditure compared to H1 2023.

 

MISSION has a significant second-half weighting with respect to profitability. Revenue growth is anticipated across all sectors and the Group remains on track to meet full-year headline operating profit expectations.

 

BALANCE SHEET

 

Total debt has reduced significantly, with debt including outstanding acquisition obligations estimated at £23.7m on 30 June 2024. This represents a reduction of £1.5m compared to the position of £25.2m at 31 December 2023.

 

Net bank debt is estimated at £19.6m at 30 June 2024. The HMRC Time To Pay creditor which stood at £4.3m as at 31 December 2023 has been fully repaid.

 

 

VALUE RESTORATION PLAN

 

The Group continues to make good progress against the Value Restoration Plan announced on 17 January 2024, with the vast majority of the £5.0m of annualised projected profit improvements already secured for the year. Planned cost savings and operating efficiency improvements are tracking to expectations for full delivery by the end of 2024.

 

Alongside the successful refinancing of the existing debt facility with long-standing lender NatWest announced on 28 March 2024, the Group also continues to progress discussions regarding options to deleverage its balance sheet. A further update will be provided when appropriate.

 

NOTICE OF RESULTS

 

The Group expects to announce its interim results for the six months ended 30 June 2024 towards the end of September 2024.

 

Chief Executive of MISSION, James Clifton, commented: "I am pleased to report ongoing momentum across the Group, with new Client wins driving revenue growth alongside continued debt reduction and increased efficiency across our operations.

We are delivering on our strategy for 2024 and 2025 to create value for all stakeholders.

 

We enter H2 in a positive mood with a strong pipeline of new business opportunities and robust confidence in the long-term outlook for the Group."

 

ENDS

1. Headline results are calculated before acquisition adjustments, start-up costs and exceptional restructuring costs.

2. Continuing activities exclude the results of the Group's 80% interest in Pathfindr which was sold in December 2023.

 

ENQUIRIES

 

James Clifton, Chief Executive Officer

Giles Lee, Chief Financial Officer

The MISSION Group plc

 

Via Houston

 

Simon Bridges/Andrew Potts/Harry Rees

Canaccord Genuity Limited (Nominated Adviser and Broker)

020 7523 8000

 

Kate Hoare / Alexander Clelland / India Spencer

HOUSTON (Financial PR and Investor Relations)

0204 529 0549

 

 

NOTES TO EDITORS

 

The MISSION Group Plc. is The Brand Performance Group 

Delivering measurable, results-driven campaigns as the preferred creative partner for real business growth. We offer top-tier agencies, strategic specialisms and global reach delivering outstanding performance for brands. We call it Work That Counts™ www.themission.co.uk 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse (Amendment) (EU Exit) Regulations 2019. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUSSNRSSUBUAR
Date   Source Headline
22nd Sep 20217:00 amRNSInterim Results for six months to 30 June 2021
14th Jul 20217:00 amRNSTRADING UPDATE AND NOTICE OF INTERIM RESULTS
28th Jun 20217:00 amRNSGrowth Share Scheme
25th Jun 20212:17 pmRNSHolding(s) in Company
15th Jun 20217:00 amRNSDirector/PDMR Shareholding
14th Jun 20211:38 pmRNSResult of AGM
14th Jun 20217:00 amRNSTR1: Notification of Major Holdings
11th May 20219:19 amRNSHolding(s) in Company
30th Apr 20217:00 amRNSDirectorate Changes
26th Apr 20215:05 pmRNSCorrection: Director/PDMR Shareholding
26th Apr 202112:15 pmRNSDirector/PDMR Shareholding
19th Apr 20216:04 pmRNSDirector/PDMR Shareholding
14th Apr 20217:01 amRNSFinal Results for the Year Ended 31 December 2020
14th Apr 20217:00 amRNSChanges to the Board
11th Mar 20214:40 pmRNSDirector/PDMR Shareholding
24th Feb 20217:00 amRNSHolding(s) in Company
22nd Feb 20215:37 pmRNSDirector/PDMR Shareholding
9th Feb 20219:24 amRNSDirector/PDMR Shareholding
25th Jan 20214:40 pmRNSSecond Price Monitoring Extn
25th Jan 20214:35 pmRNSPrice Monitoring Extension
20th Jan 20217:00 amRNSTrading Update and Notice of Results
11th Nov 20204:58 pmRNSHolding(s) in Company
23rd Sep 20207:00 amRNSInterim Results
27th Jul 20207:00 amRNSACQUISITION OF INNOVATIONBUBBLE
15th Jul 20207:00 amRNSTrading Statement and Notice of Interim Results
15th Jun 20203:37 pmRNSResult of AGM
21st May 20207:00 amRNSCovid-19 and AGM Update
11th May 20204:58 pmRNSDirector Dealing and Issue of Consideration Shares
17th Apr 20203:36 pmRNSIssue of Equity
7th Apr 20205:00 pmRNSPDMR Shareholding pursuant to Growth Share Scheme
1st Apr 20207:00 amRNSFinal Results for the year ended 31 December 2019
27th Mar 20205:22 pmRNSCOVID-19 UPDATE
25th Mar 202011:05 amRNSSecond Price Monitoring Extn
25th Mar 202011:00 amRNSPrice Monitoring Extension
13th Mar 20202:22 pmRNSHolding(s) in Company
22nd Jan 20207:00 amRNSTrading Update
9th Dec 201911:55 amRNSDirector/PDMR Shareholding
5th Dec 20197:00 amRNSLaunch of Global Competition
25th Sep 20197:00 amRNSChange of Name
25th Sep 20197:00 amRNSHalf-year Report
13th Aug 20197:00 amRNSEBT Share Dealings
7th Aug 20198:15 amRNSEBT Share Dealings
1st Aug 20191:11 pmRNSDirector/PDMR Shareholding - Replacement
1st Aug 20197:00 amRNSDirector/PDMR Shareholding
15th Jul 20197:00 amRNSTrading Update
17th Jun 201912:57 pmRNSResult of AGM
17th Jun 201911:58 amRNSBoard Changes
12th Jun 20195:26 pmRNSDirector/PDMR Shareholding
7th Jun 20199:34 amRNSEBT Share Dealings
6th Jun 20191:17 pmRNSEBT Share Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.